Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 May;38(5):770–774. doi: 10.1136/gut.38.5.770

Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.

S S Elsayed 1, G Shiha 1, M Hamid 1, F M Farag 1, F Azzam 1, M Awad 1
PMCID: PMC1383163  PMID: 8707127

Abstract

BACKGROUND--This trial was carried out to assess the value of propranolol in the prevention of recurrent variceal bleeding when combined with longterm endoscopic sclerotherapy. PATIENTS AND METHODS--Two hundred patients (161 male, 39 female, age range 20-68 years) with portal hypertension resulting mainly from schistosomal periportal fibrosis or posthepatitic cirrhosis presenting with their first episode of haematemesis or melena, or both were included. This was confirmed endoscopically to result from ruptured oesophageal varices. After initial control of bleeding, patients were randomised into two groups: group 1 treated with endoscopic sclerotherapy alone and group 2 treated with sclerotherapy plus propranolol. They were followed up for two years. RESULTS--Group (2) had a lower rebleeding rate (14.3% v 38.6% in group 1), lower variceal recurrence after obliteration (17% v 34% in group 1), longer period between variceal obliteration and recurrence (36 weeks v 21 weeks in group 1); but no change in mortality (12% in both groups). CONCLUSIONS--Patients treated with sclerotherapy should be given propranolol for longterm management.

Full text

PDF
771

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balanzó J., Such J., Sainz S., González D., Guarner C., Allende L., Lacalle J. P., Vilardell F. Long term survival and severe rebleeding after variceal sclerotherapy. Surg Gynecol Obstet. 1990 Dec;171(6):489–492. [PubMed] [Google Scholar]
  2. Binmoeller K. F., Grimm H., Soehendra N. Treatment of esophageal varices. Endoscopy. 1992 Jan-Feb;24(1-2):52–57. doi: 10.1055/s-2007-1010441. [DOI] [PubMed] [Google Scholar]
  3. Cordeiro F. Variceal sclerosis in schistosomotic patients: a 5-year follow-up study. Gastrointest Endosc. 1990 Sep-Oct;36(5):475–478. doi: 10.1016/s0016-5107(90)71118-2. [DOI] [PubMed] [Google Scholar]
  4. Garrett K. O., Reilly J. J., Jr, Schade R. R., van Thiel D. H. Bleeding esophageal varices: treatment by sclerotherapy and liver transplantation. Surgery. 1988 Nov;104(5):819–823. [PubMed] [Google Scholar]
  5. Graham D. Y., Smith J. L. The course of patients after variceal hemorrhage. Gastroenterology. 1981 Apr;80(4):800–809. [PubMed] [Google Scholar]
  6. Hashizume M., Kitano S., Koyanagi N., Tanoue K., Ohta M., Wada H., Yamaga H., Higashi H., Iso Y., Iwanaga T. Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: a nine-year prospective study. Hepatology. 1992 Jan;15(1):69–75. doi: 10.1002/hep.1840150114. [DOI] [PubMed] [Google Scholar]
  7. Hayes P. C., Crichton S., Shepherd A. N., Bouchier I. A. Propranolol in chronic liver disease: a controlled trial of its effect and safety over twelve months. Q J Med. 1987 Oct;65(246):823–834. [PubMed] [Google Scholar]
  8. Jensen L. S., Krarup N. Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy. Scand J Gastroenterol. 1989 Apr;24(3):339–345. doi: 10.3109/00365528909093057. [DOI] [PubMed] [Google Scholar]
  9. Jensen L. S., Krarup N. Propranolol may prevent recurrence of oesophageal varices after obliteration by endoscopic sclerotherapy. Scand J Gastroenterol. 1990 Apr;25(4):352–356. doi: 10.3109/00365529009095498. [DOI] [PubMed] [Google Scholar]
  10. Kanazawa H., Watari A., Matsusaka S., Tada N., Miyata K., Saitoh H., Yoshizawa M., Kuroda H., Kobayashi M. [Prospective controlled study of elective sclerotherapy plus oral propranolol for prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage]. Nihon Shokakibyo Gakkai Zasshi. 1991 Jun;88(6):1341–1348. [PubMed] [Google Scholar]
  11. Lebrec D., Nouel O., Corbic M., Benhamou J. P. Propranolol--a medical treatment for portal hypertension? Lancet. 1980 Jul 26;2(8187):180–182. doi: 10.1016/s0140-6736(80)90063-x. [DOI] [PubMed] [Google Scholar]
  12. Lundell L., Leth R., Lind T., Lönroth H., Sjövall M., Olbe L. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions. Acta Chir Scand. 1990 Oct;156(10):711–715. [PubMed] [Google Scholar]
  13. Lyra L. G., Rebouças G., Andrade Z. A. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterology. 1976 Oct;71(4):641–645. [PubMed] [Google Scholar]
  14. O'Connor K. W., Lehman G., Yune H., Brunelle R., Christiansen P., Hast J., Compton M., McHenry R., Klatte E., Cockerill E. Comparison of three nonsurgical treatments for bleeding esophageal varices. Gastroenterology. 1989 Mar;96(3):899–906. [PubMed] [Google Scholar]
  15. RAMOS O. L., SAAD F., LESER W. P. PORTAL HEMODYNAMICS AND LIVER CELL FUNCTION IN HEPATIC SCHISTOSOMIASIS. Gastroenterology. 1964 Sep;47:241–247. [PubMed] [Google Scholar]
  16. Rossi V., Calès P., Burtin P., Charneau J., Person B., Pujol P., Valentin S., D'Aubigny N., Joubaud F., Boyer J. Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy. J Hepatol. 1991 May;12(3):283–289. doi: 10.1016/0168-8278(91)90828-y. [DOI] [PubMed] [Google Scholar]
  17. Routledge P. A., Shand D. G. Clinical pharmacokinetics of propranolol. Clin Pharmacokinet. 1979 Mar-Apr;4(2):73–90. doi: 10.2165/00003088-197904020-00001. [DOI] [PubMed] [Google Scholar]
  18. Tarver D., Walt R. P., Dunk A. A., Jenkins W. J., Sherlock S. Precipitation of hepatic encephalopathy by propranolol in cirrhosis. Br Med J (Clin Res Ed) 1983 Aug 27;287(6392):585–585. doi: 10.1136/bmj.287.6392.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Terblanche J., Bornman P. C., Kahn D., Jonker M. A., Campbell J. A., Wright J., Kirsch R. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet. 1983 Dec 10;2(8363):1328–1332. doi: 10.1016/s0140-6736(83)91090-5. [DOI] [PubMed] [Google Scholar]
  20. Terblanche J. The surgeon's role in the management of portal hypertension. Ann Surg. 1989 Apr;209(4):381–395. doi: 10.1097/00000658-198904000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Villeneuve J. P., Pomier-Layrargues G., Infante-Rivard C., Willems B., Huet P. M., Marleau D., Viallet A. Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology. 1986 Nov-Dec;6(6):1239–1243. doi: 10.1002/hep.1840060602. [DOI] [PubMed] [Google Scholar]
  22. Westaby D., Melia W., Hegarty J., Gimson A. E., Stellon A. J., Williams R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology. 1986 Jul-Aug;6(4):673–675. doi: 10.1002/hep.1840060422. [DOI] [PubMed] [Google Scholar]
  23. Westaby D., Polson R. J., Gimson A. E., Hayes P. C., Hayllar K., Williams R. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Hepatology. 1990 Mar;11(3):353–359. doi: 10.1002/hep.1840110304. [DOI] [PubMed] [Google Scholar]
  24. Wood A. J., Kornhauser D. M., Wilkinson G. R., Shand D. G., Branch R. A. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration. Clin Pharmacokinet. 1978 Nov-Dec;3(6):478–487. doi: 10.2165/00003088-197803060-00005. [DOI] [PubMed] [Google Scholar]
  25. Yassin Y. M., Sherif S. M. Randomized controlled trial of injection sclerotherapy for bleeding oesophageal varices--an interim report. Br J Surg. 1983 Jan;70(1):20–22. doi: 10.1002/bjs.1800700107. [DOI] [PubMed] [Google Scholar]
  26. de Dombal F. T., Clarke J. R., Clamp S. E., Malizia G., Kotwal M. R., Morgan A. G. Prognostic factors in upper G.I. bleeding. Endoscopy. 1986 May;18 (Suppl 2):6–10. doi: 10.1055/s-2007-1018418. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES